Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IoM Supplement Monograph Framework Should Reflect “Real World” – CFSAN

This article was originally published in The Tan Sheet

Executive Summary

Monographs created under IoM's Framework for Evaluating the Safety of Dietary Supplements should serve as templates for FDA or industry to use in crafting their own ingredient monographs, rather than requiring a comprehensive literature review, Center for Food Safety & Applied Nutrition reps said

You may also be interested in...



Ephedra “Black Box” Warning Considered By FDA

FDA is suggesting that a "black box" warning appear on the principal display panel of all ephedrine alkaloid-containing dietary supplements, FDA Commissioner Mark McClellan, MD/PhD, said during a Feb. 28 briefing held in Washington, D.C

Melatonin, Chromium Monograph Human Safety Data Should Be Used – CRN

Animal and in vitro studies are not useful in crafting safety monographs for melatonin and chromium picolinate because there is adequate human data available, according to Council for Responsible Nutrition VP-Nutritional & Regulatory Science John Hathcock, PhD

Three-Step Supplement Safety Review Model Proposed by IoM

Outside review organizations could play a key role in preparing dietary supplement safety monographs as part of the Institute of Medicine's Proposed Framework for Evaluating the Safety of Dietary Supplements

Related Content

Topics

UsernamePublicRestriction

Register

PS095397

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel